Procept Biorobotics Corp (PRCT)
Healthcare
Medical Devices
18.60 $
+3.4%
vs. previous close
Closing price · As of: 31. Jul 2026
Procept Biorobotics Corp (PRCT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -49 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| -44 | -48 | -57 | -80 | -108 | -99 | -49 | |
| 1.5 | 2.9 | 3.3 | 2.8 | 3.8 | 5.2 | 6.4 | |
| 2.0 | 2.2 | 3.8 | 10 | 19 | 32 | 48 | |
| 0.2 | 2.3 | 4.4 | 15 | – | – | – | |
| -3.5 | -0.5 | -4.7 | -11 | -26 | -47 | -7.8 | |
| 7.6 | 0.2 | 0.6 | 2.7 | 25 | 4.4 | 9.4 | |
| 43 | -0.2 | -0.6 | -2.7 | -25 | -4.4 | -9.4 | |
| – | – | 177 | 2.4 | 3.6 | 4.5 | 6.4 | |
| 25 | 25 | 1.2 | 1.2 | 0.0 | 0.0 | – | |
| 27 | 107 | 262 | 3.6 | 168 | 180 | 11 | |
| 26 | 58 | 204 | -79 | 35 | 77 | -47 | |
| -51 | -49 | -58 | -83 | -133 | -104 | -58 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.